Results 1 to 10 of about 26,691 (223)

DERIVATIVES OF DIHYDROPYRIDINE AND PRODUCTION THEREOF

1984
KIMURA KIYOSHI, MORITA IWAO, MORIMURA SEIICHIRO   +2 more
openaire   +2 more sources

Dihydropyridine combination product comprising a dihydropyridine compound and a cardioactive nitrate

1989
GROSS RAINER, SCHRAMM MATTHIAS
openaire   +1 more source

Pharmaceutical composition of dihydropyridine compound.

1989
MIYAJIMA MASAHARU, YAMAGUCHI YUKIYA, TSUNEMATSU TAKAO, ODA TOSHIHISA   +3 more
openaire   +2 more sources

RESOLUTION OF 1,4-DIHYDROPYRIDINE DERIVATIVES

1990
openaire   +2 more sources

Dimethyl 4-(4-formylphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

Acta Crystallographica Section E, 2008
The title compound, C18H19NO5, is a product of the Hantzsch reaction of p-phthalaldehyde, methyl acetoacetate, and ammonium acetate. The 1,4-dihydropyridine ring of the molecule adopts a flattened boat conformation.
Fei Teng, Fanpeng Kong, Qingjian Liu
doaj   +2 more sources

Diethyl 4-(2,4-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

Acta Crystallographica Section E, 2010
In the title compound, C19H21Cl2NO4, the dihydropyridine ring adopts a flattened boat conformation. The dichlorophenyl ring is oriented almost perpendicular to the planar part of the dihydropyridine ring [dihedral angle = 89.1 (1)&#176 ...
P. Palakshi Reddy, V. Vijayakumar, J. Suresh, T. Narasimhamurthy, P. L. Nilantha Lakshman   +4 more
doaj   +3 more sources

Dihydropyridine Calcium Channel Blocker Therapy and Risk of CKD Progression in Type 2 Diabetes Treated With Renin Angiotensin System Inhibitors and SGLT2 Inhibitors: A Real-World Retrospective Cohort Study. [PDF]

Kidney Med
Rationale & Objective: Optimal antihypertensive therapy with renoprotective effects is essential to slow diabetic kidney disease progression. We evaluated the impact of dihydropyridine calcium channel blockers on kidney outcomes in patients with type
Agur T, Steinmetz T, Goldman S, Zingerman B, Bielopolski D, Nesher E, Fattal I, Meisel E, Rozen-Zvi B.   +8 more
europepmc   +2 more sources

Dihydropyridine calcium blockers do not interfere with non-rapid eye movement sleep

Frontiers in Neuroscience, 2022
Non-rapid eye movement (NREM) sleep is tightly homeostatically regulated and essential for survival. In the electroencephalogram (EEG), oscillations in the delta (0.5–4 Hz) range are prominent during NREM sleep. These delta oscillations are, to date, the
GoEun Han, Sumire Matsumoto, Javier Diaz, Robert W. Greene, Robert W. Greene, Kaspar E. Vogt   +5 more
doaj   +1 more source

A Dihydropyridine Derivative as a Highly Selective Fluorometric Probe for Quantification of Au³⁺ Residue in Gold Nanoparticle Solution

Sensors, 2022
Novel dihydroquinoline derivatives (DHP and DHP-OH) were synthesized in one pot via a tandem trimerization-cyclization of methylpropiolate. DHP and DHP-OH possess strong blue fluorescence with high quantum efficiencies over 0.70 in aqueous media.
Waroton Paisuwan, Mongkol Sukwattanasinitt, Mamoru Tobisu, Anawat Ajavakom   +3 more
doaj   +1 more source

Amlodipine Overdose: Is High Dose Insulin Ready for Prime Time

Hearts, 2022
Overdose of amlodipine, a dihydropyridine calcium channel blocker (CCB), is distinguished from other CCBs due to longer plasma half-life of 30 to 58 h.
Mary Jo S. Farmer, Anisha Contractor, Joshua Allgaier   +2 more
doaj   +1 more source